Du är här


Hofseth Biocare ASA : Hofseth BioCare - EGM - approval of private placement

An EGM in Hofseth BioCare were held in Moloveien, Ålesund on Friday 2 May

All items, including the proposal for approval of a private placement of NOK
90 millions, were approved in accordance with the notice for the EGM and the
subsequent amendment to the notice, as specified in a stock exchange notice
dated 30 April 2014.

A statement from the Company's auditor regarding conversion of debt is
attached (in Norwegian only).

A prospectus in regards to the listing of the shares issued under the private
placement will be published as soon as it is approved by the Norwegian FSA.

For further information, please contact:
Jon Olav Ødegård, CEO Hofseth BioCare ASA
Tel: +47 936 32 966
E-mail: joo@h-bc.no

About Hofseth BioCare:

Hofseth BioCare is a Norwegian biomarine company with the key objective to
provide high value added biomarine ingredients for human applications. The
Company is founded on the core value of sustainability and optimal use of
natural resources. Through innovative production technology and logistics,
Hofseth BioCare is able to preserve the quality of protein, calcium and oil
extracted from fish off-cuts. Products that previously could only be used as
animal feed can now be made suitable for human consumption. HBCs objective is
thus to contribute to efficient use of marine resources and entering the
higher profit market of quality ingredients for human applications.

This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.

Statement regarding conversion of debt
Protokol EGM


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Hofseth Biocare ASA via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.